Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
For full access to this article login to GEN Select now.
Getting a Handle on Nanobiotech Products
Regulators and Companies Are Laying the Groundwork for a Predicted Bright Future
- As the regulatory pathway to approval for biotech products becomes more arduous, lengthy, and expensive, biofirms are fighting to keep pace with a rapidly changing regulatory landscape. They also are trying to find out how the FDA is going to look at nanotechnology product development. A number of biotech ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.